Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002888698 | SCV003647229 | uncertain significance | Inborn genetic diseases | 2022-11-03 | criteria provided, single submitter | clinical testing | The c.3029T>G (p.F1010C) alteration is located in exon 16 (coding exon 16) of the IGF1R gene. This alteration results from a T to G substitution at nucleotide position 3029, causing the phenylalanine (F) at amino acid position 1010 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |